MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Bausch Health Cos Inc

Suletud

SektorTervishoid

5.47 6.01

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

5.12

Max

5.47

Põhinäitajad

By Trading Economics

Sissetulek

190M

98M

Müük

49M

2.6B

Aktsiakasum

1.16

Kasumimarginaal

3.83

Töötajad

20,700

EBITDA

206M

853M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+50.55% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

30. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-595M

1.7B

Eelmine avamishind

-0.54

Eelmine sulgemishind

5.47

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

Bausch Health Cos Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. apr 2025, 13:12 UTC

Omandamised, ülevõtmised, äriostud

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

17. okt 2024, 23:57 UTC

Kuumad aktsiad

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

Võrdlus sarnastega

Hinnamuutus

Bausch Health Cos Inc Prognoos

Hinnasiht

By TipRanks

50.55% tõus

12 kuu keskmine prognoos

Keskmine 8.25 USD  50.55%

Kõrge 12 USD

Madal 5 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Bausch Health Cos Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

6 ratings

0

Osta

5

Hoia

1

Müü

Tehniline skoor

By Trading Central

4.52 / N/AToetus ja vastupanu

Lühikene perspektiiv

Very Strong Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.